Axsome Therapeutics AXSM Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's common stock?
- Axsome Therapeutics (AXSM) reported common stock of $5K in Q1 2026.
- How has Axsome Therapeutics's common stock changed year-over-year?
- Axsome Therapeutics's common stock decreased by 0.0% year-over-year, from $5K to $5K.
- What is the long-term trend for Axsome Therapeutics's common stock?
- Over 5 years (2020 to 2025), Axsome Therapeutics's common stock has grown at a 6.0% compound annual growth rate (CAGR), from $3.74K to $5K.
- What does common stock mean?
- The total par value of all common shares issued by the company.
- How do you interpret common stock?
- Changes typically reflect share issuance for capital raising or stock-based compensation programs.
- How does common stock compare across companies?
- Standardized across all public companies based on par value accounting rules.